New imaging tools aim to take the guesswork out of muscle pain diagnosis
NCT ID NCT06060925
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
Myofascial pain syndrome is common but hard to diagnose accurately. This completed study tested several imaging and electrical measurement tools—like ultrasound and muscle activity sensors—to find objective signs of the condition. Researchers studied 96 adults to see if these tools can reliably detect tissue changes linked to pain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate, non-invasive diagnosis of myofascial pain and help match patients to the best treatments.
- What could go wrong
- This is an early, observational study focused on measurement, not treatment. The biomarkers may not prove reliable enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
96 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Our chosen pain condition is chronic neck and shoulder pain. We will recruit two groups of subjects: Group 1: Chronic myofascial pain as determined by baseline clinical examination (using Travell and Simons criteria) and Group 2: pain free controls. We will focus on two standardized anatomical locations. This will enable imaging the medial upper trapezius and the infraspinatus muscles, which are common locations for MTrPs56as well as the levator scapulae.These three muscles have quite different morphology and fasciae46.The levator is a fusiform muscle with well-defined fascia that includes the musclewhile the trapezius has thinner fasciafrom where perimysiumseptae crossthe muscle belly.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 and older Exclusion Criteria: * Diagnosis of fibromyalgia, chronic fatigue syndrome or chronic Lyme disease confirmed by physical exam * Diagnosis of cervical radiculopathy, neuropathy or neuriitis * History of head, neck, or shoulder girdle surgery * Atypical facial neuralgia * New medication or change in medication in past 6 months * Current throat or ear infection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
George Mason University
Fairfax, Virginia, 22030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The effects of external nasal dilator strips on sleep and cardiovascular health
- A pharmacokinetic study of NTI164 in healthy adult volunteers
- Genetic determinants of Exercise-Induced muscle damage (POLYGENDOMUS) / déterminants génétiques des dommages musculaires induits par l'Exercice (POLYGENDOMUS)
- Can a simple injection timing reduce bleeding after skin cancer surgery?
- Can Land-Based teachings shape psychedelic therapy training?
- Can a new oral drug pass early safety tests?